Informatie:
Fout:
ID
12122
Beschrijving
Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels; ODM derived from: https://clinicaltrials.gov/show/NCT02375828
Link
https://clinicaltrials.gov/show/NCT02375828
Trefwoorden
Versies (1)
- 25-09-15 25-09-15 - Julian Varghese
Geüploaded op
25 september 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Neonatal Diabetes Secondary to Mutation in the Potassium Channel NCT02375828
Eligibility Neonatal Diabetes Secondary to Mutation in the Potassium Channel NCT02375828
- StudyEvent: Eligibility
Similar models
Eligibility Neonatal Diabetes Secondary to Mutation in the Potassium Channel NCT02375828
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
age below 18 years
Item
age below 18 years
boolean
C0001779 (UMLS CUI [1])
Neonatal diabetes mellitus
Item
neonatal diabetes secondary to documented mutation in one of the 2 sub units of potassium channels
boolean
C0158981 (UMLS CUI [1])
glibenclamide; treated by
Item
patients already treated by glibenclamide pills
boolean
C0017628 (UMLS CUI [1])
informed consent
Item
signed consent
boolean
C0021430 (UMLS CUI [1])
unable to fill in the questionnaries
Item
families unable to fill in the questionnaries
boolean
C3273494 (UMLS CUI [1,1])
C3714738 (UMLS CUI [1,2])
C3714738 (UMLS CUI [1,2])
unable to answer to the visual hedonic squale
Item
patients unable to answer to the visual hedonic squale
boolean
unable to take the oral solution
Item
patients unable to take the oral solution
boolean
C0085732 (UMLS CUI [1,1])
C1720654 (UMLS CUI [1,2])
C1720654 (UMLS CUI [1,2])
antibiotic; other; allergy
Item
known allergy to sulfonylureas or to other antidiabetic or antibiotic sulfamides
boolean
C0020517 (UMLS CUI [1,1])
C0038766 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0935929 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0038703 (UMLS CUI [3,2])
C0038766 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0935929 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0038703 (UMLS CUI [3,2])
insulin therapy; glibenclamide
Item
insulin therapy associated to glibenclamide
boolean
C0557978 (UMLS CUI [1])
C0017628 (UMLS CUI [2])
C0017628 (UMLS CUI [2])
miconazole; therapy
Item
miconazole therapy
boolean
C0025942 (UMLS CUI [1])
porphyria
Item
porphyria
boolean
C3463940 (UMLS CUI [1])
breast feeding
Item
breast feeding
boolean
C0006147 (UMLS CUI [1])
creatinine clearance; severe renal failure
Item
severe renal failure (creatinine clearance below 30 ml/mn)
boolean
C0373595 (UMLS CUI [1])
liver failure (prothombine time below 70)
Item
liver failure (prothombine time below 70)
boolean
C0030605 (UMLS CUI [1])
affiliated to the health care system
Item
not affiliated to the health care system
boolean
C0029239 (UMLS CUI [1])